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Indigenous and First Nation peoples: terminology 
The recommendations from ‘Communicating Positively, A guide to appropriate Aboriginal 
terminology’ 2 and ‘The Australian Indigenous HealthInfoNet guidelines for Aboriginal and 
Torres Strait Islander terminology’ 3 have guided reference to Aboriginal and Torres Strait 
Islander peoples in this thesis.  
Terms such as Aboriginal peoples, Aboriginal and Torres Strait Islander peoples and 
Indigenous have all been used in the literature. I have used the terms non-Indigenous and 
non-Aboriginal interchangeably when referring to all other non-Indigenous Australians. 
The term Indigenous is capitalized as a form of respect. When making international 
comparisons I have used the term Indigenous in general; when quoting from other sources I 
have used the term used in that material. 
The term Māori refers to Indigenous peoples of New Zealand (NZ) and Pasifika refers to 
people living in New Zealand (or Australia) who have migrated from the Pacific Islands or 
who identify with the Pacific Islands because of ancestry or heritage 4. 
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Abstract 
Background 
In the twenty-first century, rheumatic heart disease (RHD) persists in low- and middle-
income countries as well as vulnerable populations in high-income countries, particularly 
Indigenous peoples. RHD in pregnancy (RHD-P) is associated with an increased burden of 
maternal mortality and morbidity, poorer perinatal outcomes, and compromised care 
pathways. There is inadequate knowledge regarding models of care for women with RHD-P. 
This research identifies and examines gaps and facilitators of optimal care for women with 
RHD-P with a focus on Australian health services. 
Methods 
The mixed methods research employed a transformative parallel design lens, providing a 
mechanism with which to address the political and social complexities of research in the 
RHD-P arena and in turn establishing a framework for change. 
The study comprises three elements. The first involved a systematic review and qualitative 
synthesis of the peer-reviewed literature, that explored approaches to care provision for 
women with RHD-P and examine reported measures. It applied content analysis to examine 
models of care and clinical care reporting measures. 
The second element entailed a descriptive qualitative study that explored 19 health 
professionals’ perspectives of care pathways for women with RHD-P. The semi-structured 
interviews were analysed thematically. 
The final study conducted a process evaluation of the implementation of a population-
based study of RHD-P in Australia. It examined the operationalising of the research project, 
and evaluated strategies developed to strengthen reporting and improve awareness of the 
impact of RHD during pregnancy among health services. 
Findings 
The studies identified gaps related to health systems, health workforces and health 
information that impacted on effective models of care. 
The systematic review found that key reporting measures in studies that refer to RHD-P 
were poorly recorded.  
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The qualitative study of health professionals’ perspectives of RHD-P identified a 
constellation of factors that challenged the provision of cohesive women-centred health 
care. Themes included conduits of care - helping to break down silos of information, 
processes and access; ‘layers on layers’ – reflecting the complexity of care issues; and 
shared understandings – factors that contributed to improved understandings of disease, 
informed decision-making, and the inclusion of family and community members. 
The process evaluation of the population level study of RHD-P exemplified several of the 
themes arising from the previous two studies. Effective reporting was negatively impacted 
by a lack of diagnostic certainty; incompatible health information systems and varying 
clinical awareness among health professionals.  
Discussion 
This research found that, despite often complex care requirements, pregnancy for women 
with RHD provides a unique opportunity to strengthen health system responses, improve 
care pathways, address whole of life health and ultimately reduce the burden of RHD for 
women. To respond effectively, structural and cultural changes are required to improve 
health system agility and capability. This includes enhanced investment in education and 
capacity building – particularly in maternal health – to support a better informed and skilled 
workforce; and improved information systems and reporting of core indicators to more 
accurately benchmark care pathways, outcomes and burden of RHD-P. 
Conclusion 
Central to the provision of informed, respectful collaborative care for women with RHD is 
timely diagnosis, access to health services and continuity of care. The research 
recommendations based on study findings aim to better achieve these goals and, in doing 
so, ensure the needs of vulnerable women with RHD are better met. 
 
